ArticleNanoscale2021

CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer.

Shanta Bhattarai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.